 |
VBI Vaccines
Last updated: October 09, 2024
Jeff Baxter, President and Chief Executive Officer
USA | Funding: $765M (+)
Website: http://www.vbivaccines.com
VBI Vaccines is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. VBI’s eVLP vaccine platform allows for the design of enveloped virus-like particle vaccines that closely mimic the target virus.
Website: http://www.vbivaccines.com
VBI Vaccines is a biopharmaceutical company developing novel technologies that seek to expand vaccine protection in large underserved markets. VBI’s eVLP vaccine platform allows for the design of enveloped virus-like particle vaccines that closely mimic the target virus.
